Isothiazolones lower plasma levels of lipoprotein(a)
US5668162A · kind A · utility
13Cited by
12References
17Claims
0Family size
Inventors
Key dates
| Filing date | May 7, 1996 |
| Grant date | Sep 16, 1997 |
| Priority date | — |
| Expiry date | May 7, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Plasma levels of Lp(a) are lowered by administering an isothiazolone having the general structure ##STR1## where A is a monocyclic or bicyclic ring which may contain up to 3 heteroatoms selected from O, S, and N; R.sup.1 and R.sup.2 are substituent groups such as alkyl, alkoxy, hydroxy, nitro, cyano, amino, and carboxy; and R.sup.5 is alkyl, cycloalkyl, phenyl, and Het.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.